At Peptomyc we believe in forging strategic partnerships that will ultimately enable us to drive Myc inhibition into the clinic as an effective anti-cancer therapy across multiple tumor types. We therefore welcome your interest, questions or any queries you may have surrounding Peptomyc.

Please do contact us directly:

Laura Soucek
(Chief-Executive-Officer)
lsoucek@peptomyc.com

Marie-Eve Beaulieu
(Chief-Scientific-Officer)
mbeaulieu@peptomyc.com